- Article
- Source: Campus Sanofi
Webinar Recording: Navigating Type-2 Inflammation in Severe Asthma and COPD1
Missed this webinar? You can now watch the recording of the webinar to learn about the role of biologics in severe asthma and COPD1 through real-world clinical cases presented by a panel of expert clinicians.
What is this webinar about?
Join us for a dynamic case discussion featuring real-life scenarios and the latest strategies of severe asthma and COPD1 management with biologic, led by:
Prof. Chin Kook Rhee (Chairperson), Konkuk University Medical Centre
Asst. Prof. Tiew Pei Yee (Chairperson), SGH
Dr. Jolene Liu (Speaker), SKH
Dr. Haly Rozie Binti Ahmad (Speaker), Serdang Hospital
Navigating Type-2 Inflammation in Severe Asthma and COPD1
1. Please note that dupilumab is not indicated for COPD in Malaysia.
Advanced Airways Collaborative: Asthma & COPD Case Discussion
Missed the live session? You can now watch the Advanced Airways Collaborative webinar on-demand.
ATS 2026 Highlights: COPD & Asthma Biologic Insights
Explore ATS 2026 key sessions on dupilumab, COPD biologics, FeNO biomarkers, and asthma remission. Real-world evidence for HCPs
AAD 2026: Dermatology Updates Denver
AAD 2026 post-congress: Complete systemic therapy update. Multi-indication clinical data for inflammatory dermatological conditions.
Patient-Video
Request-form
